Insulin Prices are Increasing!

Congress, AMA on alert as insulin prices soar

The Washington Post (1/7, Stanley) reports in-depth on the rising cost of insulin, “making the lifesaving medication a significant, even burdensome, expense, especially for the uninsured and underinsured.” Indeed, an IBM Watson Health analysis found the cost of insulin in the U.S. has tripled in the last ten years. The rising cost of insulin is now on the radar of Congress, and “the American Medical Association called on the government ‘to monitor insulin pricing and market competition and take enforcement actions as appropriate.’” The Post notes “Alex Azar, the head of the Department of Health and Human Services, was the president of Eli Lilly’s U.S. division until 2017,” and that Eli Lilly is among the top manufacturers of insulin. In December, meanwhile, FDA Commissioner Scott Gottlieb, M.D., issued a statement, saying, “We’ve heard frequent reports of patients rationing insulin, and in some cases dying because they can’t afford the injections they need to survive. These tragic stories aren’t isolated occurrences. And they’re not acceptable for a drug that’s nearly a century old.”

You Might Also Enjoy...

Regenerative Medicine is Here!

We are so proud to announce that we can now provide you with regenerative medicine therapy.  Our clinic is utilizing stem cells from Liveyon.  We use umbilical cord stem cells. What is this good for?